Staphylococcus aureus surface and virulence factor epitopes (S. aureus surface/virulence epitopes)

Staphylococcus aureus surface and virulence factor epitopes encompass a broad range of molecular structures used by the pathogen to colonize hosts, evade immune detection, and cause tissue damage. These targets include Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs) such as Clumping factor A (ClfA), which are essential for bacterial adhesion to host extracellular matrix components (PMID: 25103155). Additionally, the category includes potent exotoxins like alpha-hemolysin (Hla) that form pores in host cell membranes, leading to cell death and inflammation (PMID: 24123377). Immune evasion factors, such as Protein A (SpA), which interferes with antibody-mediated phagocytosis, also serve as critical epitopes for therapeutic intervention (PMID: 30139813). Therapeutic strategies targeting these epitopes involve monoclonal antibodies designed to neutralize toxins or vaccines intended to elicit protective opsonophagocytic antibodies. While these epitopes are vital for S. aureus pathogenesis, the high degree of redundancy among virulence factors and the pathogen's ability to adapt have made the development of effective single-target therapies particularly challenging in clinical settings (PMID: 23552904).

Other names

Staphylococcus aureus antigensStaphylococcal virulence factorsS. aureus surface proteinsMSCRAMMsStaphylococcal toxinsS. aureus surface epitopes

Neutralization of bacterial toxins, inhibition of bacterial adhesion to host tissues, and enhancement of opsonophagocytosis by the host immune system.